Literature DB >> 31646742

Magnetic resonance-guided radiation therapy: A review.

Stephen Chin1,2, Cynthia L Eccles3,4, Alan McWilliam4,5, Robert Chuter4,5, Emma Walker5, Philip Whitehurst5, Joseph Berresford5, Marcel Van Herk4,5, Peter J Hoskin1,4, Ananya Choudhury1,4.   

Abstract

Magnetic resonance-guided radiation therapy (MRgRT) is a promising approach to improving clinical outcomes for patients treated with radiation therapy. The roles of image guidance, adaptive planning and magnetic resonance imaging in radiation therapy have been increasing over the last two decades. Technical advances have led to the feasible combination of magnetic resonance imaging and radiation therapy technologies, leading to improved soft-tissue visualisation, assessment of inter- and intrafraction motion, motion management, online adaptive radiation therapy and the incorporation of functional information into treatment. MRgRT can potentially transform radiation oncology by improving tumour control and quality of life after radiation therapy and increasing convenience of treatment by shortening treatment courses for patients. Multiple groups have developed clinical implementations of MRgRT predominantly in the abdomen and pelvis, with patients having been treated since 2014. While studies of MRgRT have primarily been dosimetric so far, an increasing number of trials are underway examining the potential clinical benefits of MRgRT, with coordinated efforts to rigorously evaluate the benefits of the promising technology. This review discusses the current implementations, studies, potential benefits and challenges of MRgRT.
© 2019 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Keywords:  MR-guided radiation therapy; magnetic resonance imaging; radiation oncology; radiation oncology imaging

Mesh:

Year:  2019        PMID: 31646742     DOI: 10.1111/1754-9485.12968

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  31 in total

1.  Performance evaluation of a visual guidance patient-controlled respiratory gating system for respiratory-gated magnetic-resonance image-guided radiation therapy.

Authors:  Hyung Jin Choun; Jung-In Kim; Chang Heon Choi; Seongmoon Jung; Hyeongmin Jin; Hong-Gyun Wu; Eui Kyu Chie; Jong Min Park
Journal:  Phys Eng Sci Med       Date:  2022-06-20

2.  Real-Time 2D MR Cine From Beam Eye's View With Tumor-Volume Projection to Ensure Beam-to-Tumor Conformality for MR-Guided Radiotherapy of Lung Cancer.

Authors:  Xingyu Nie; Guang Li
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

3.  Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy.

Authors:  Mutlay Sayan; Ilkay Serbez; Bilgehan Teymur; Gokhan Gur; Teuta Zoto Mustafayev; Gorkem Gungor; Banu Atalar; Enis Ozyar
Journal:  Front Oncol       Date:  2020-09-21       Impact factor: 6.244

4.  Variations in Demand across England for the Magnetic Resonance-Linac Technology, Simulated Utilising Local-level Demographic and Cancer Data in the Malthus Project.

Authors:  T Mee; A J Vickers; R Jena; K J Kirkby; A Choudhury; N F Kirkby
Journal:  Clin Oncol (R Coll Radiol)       Date:  2021-03-26       Impact factor: 4.925

5.  Clinical workflow for treating patients with a metallic hip prosthesis using magnetic resonance imaging-guided radiotherapy.

Authors:  Rick Keesman; Erik van der Bijl; Tomas M Janssen; Tineke Vijlbrief; Floris J Pos; Uulke A van der Heide
Journal:  Phys Imaging Radiat Oncol       Date:  2020-08-12

Review 6.  MR-Guided Radiotherapy: The Perfect Partner for Immunotherapy?

Authors:  Juliane Hörner-Rieber; Sebastian Klüter; Jürgen Debus; Gosse Adema; Marleen Ansems; Marcel Verheij
Journal:  Front Oncol       Date:  2021-02-02       Impact factor: 6.244

Review 7.  Single-Fraction Stereotactic Body Radiation Therapy: A Paradigm During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond?

Authors:  Sylvia S W Ng; Matthew S Ning; Percy Lee; Ryan A McMahon; Shankar Siva; Michael D Chuong
Journal:  Adv Radiat Oncol       Date:  2020-06-24

8.  [Retrospective study on the intensification of hypofractionated radiotherapy: The organizational change].

Authors:  S Corbin; G Brusadin; S Rivera; A Bossi; É Deutsch
Journal:  Cancer Radiother       Date:  2020-08-21       Impact factor: 1.018

9.  The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy.

Authors:  Sophie R de Mol van Otterloo; John P Christodouleas; Erwin L A Blezer; Hafid Akhiat; Kevin Brown; Ananya Choudhury; Dave Eggert; Beth A Erickson; Corinne Faivre-Finn; Clifton D Fuller; Joel Goldwein; Shaista Hafeez; Emma Hall; Kevin J Harrington; Uulke A van der Heide; Robert A Huddart; Martijn P W Intven; Anna M Kirby; Susan Lalondrelle; Claire McCann; Bruce D Minsky; Stella Mook; Marlies E Nowee; Uwe Oelfke; Kristina Orrling; Arjun Sahgal; Jeffrey G Sarmiento; Christopher J Schultz; Robbert J H A Tersteeg; Rob H N Tijssen; Alison C Tree; Baukelien van Triest; William A Hall; Helena M Verkooijen
Journal:  Front Oncol       Date:  2020-09-07       Impact factor: 6.244

10.  The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey.

Authors:  Enrica Seravalli; Petra S Kroon; John M Buatti; Matthew D Hall; Henry C Mandeville; Karen J Marcus; Cem Onal; Enis Ozyar; Arnold C Paulino; Frank Paulsen; Daniel Saunders; Derek S Tsang; Suzanne L Wolden; Geert O Janssens
Journal:  Clin Transl Radiat Oncol       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.